Drug Type Small molecule drug |
Synonyms Azelnidipine (JP17/INN), CS-905, RS 9054 + [5] |
Target |
Action blockers |
Mechanism L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (31 Jan 2003), |
Regulation- |
Molecular FormulaC33H34N4O6 |
InChIKeyZKFQEACEUNWPMT-UHFFFAOYSA-N |
CAS Registry123524-52-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01145 | Azelnidipine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | Japan | 31 Jan 2003 |
Not Applicable | 36 | kzqdixlncu(ecbvbyqauc) = qhbayqoirm qlrigimlcb (qbqdvegdze ) | - | 01 Feb 2020 | |||
kzqdixlncu(ecbvbyqauc) = shgwfyylyf qlrigimlcb (qbqdvegdze ) | |||||||
Not Applicable | - | wsrishosbe(hbpjrwqcxo) = fovpwcwpbp bvnknisbtj (cpzfzvvqfp ) View more | Positive | 01 Sep 2012 | |||
wsrishosbe(hbpjrwqcxo) = iqykxrfvft bvnknisbtj (cpzfzvvqfp ) View more | |||||||
Not Applicable | - | cumbuhtxui(pnwicgthsk) = ipjovezegl sbwtdxjrkl (zpvkgyzdtq, 5) View more | Positive | 01 Jun 2010 | |||
cumbuhtxui(pnwicgthsk) = ysvawwnuip sbwtdxjrkl (zpvkgyzdtq, 4) View more |